Food and Drug Administration (FDA)

See the following -

WHO Sounds Alarm On Widespread 'Superbug' Infections

Kim Painter | USA Today | April 30, 2014

Disease-causing bacteria that resist antibiotic treatment are now widespread in every part of the world and have reached "alarming levels" in many areas, says the first global report on the issue from the World Health Organization. Read More »

Why Antibiotic Makers Aren't Worried About FDA's Livestock Rules

Venessa Wong | Bloomberg Businessweek | December 12, 2013

In a move to alleviate concerns about overuse of antibiotics on farms, the U.S. Food and Drug Administration issued new guidance directing at animal pharmaceutical companies to phase out the use of certain drugs to promote weight gain in animals. But this won’t mean drug-free livestock [...]. Read More »

WIB Profile: Cutting The Length, Cost, And Complexity Of Clinical Trials

Ed Miseta | Clinical Leader | December 19, 2013

Sophie McCallum has spent almost four years with clinical solutions firm Clinovo, currently serving as its director of operations. In this position, McCallum oversees and manages the marketing, HR, finance, and inside sales departments. Read More »

YODA Project: 'Opening Up' Clinical Trials & Research Practices

By Peter Groen | June 19, 2013

Many patients and their physicians often make treatment decisions with access to only a fraction of the relevant clinical research data because details about many clinical studies or clinical trials are never made available in published biomedical literature. The YODA Project may change this. Read More »

You Can Take Selfies Of Your Aorta With This Mini Camera

Joseph Flaherty | Wired Magazine | March 18, 2014

Scientific studies of selfies have yielded interesting insights on personalities, gender differences, and national moods, but scientist F. Levent Degertekin has invented a new camera that can provide high-def, 3-D images of your innards.

Read More »

‘Superbug’ Scourge Spreads as U.S. Fails to Track Rising Human Toll

Ryan McNeill, Deborah J. Nelson and Yasmeen Abutaleb | Reuters | September 7, 2016

Fifteen years after the U.S. declared drug-resistant infections to be a grave threat, the crisis is only worsening, a Reuters investigation finds, as government agencies remain unwilling or unable to impose reporting requirements on a healthcare industry that often hides the problem...